Engineering the mouse genome to model human disease for drug discovery

Methods in Molecular Biology

Volumn 602, Issue , 2010, Pages 55-77

  Koentgen, Frank ^a   Suess, Gabriele ^a   Naf, Dieter ^a  

^a Ozgene Pty Ltd   (Australia)

Author keywords

gene targeting; homologous recombination; humanized mice; knockout; reporter gene; Transgenic mice

Indexed keywords

MUS; MUS MUSCULUS;

ANIMAL; ARTICLE; DISEASE MODEL; DRUG DEVELOPMENT; EMBRYONIC STEM CELL; GENE TARGETING; GENE TRANSFER; GENETIC ENGINEERING; GENOME; HUMAN; METHODOLOGY; MOUSE; PHYSIOLOGY; RNA INTERFERENCE; TRANSGENIC MOUSE;

ANIMALS; DISEASE MODELS, ANIMAL; DRUG DISCOVERY; EMBRYONIC STEM CELLS; GENE KNOCK-IN TECHNIQUES; GENE TARGETING; GENE TRANSFER TECHNIQUES; GENETIC ENGINEERING; GENOME; HUMANS; MICE; MICE, TRANSGENIC; RNA INTERFERENCE;

EID: 77449097284     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-60761-058-8_4     Document Type: Article

References (103)

1. Driscoll, C.A., Menotti-Raymond, M., Roca, A.L., Hupe, K., Johnson, W.E., Geffen, E., Harley, E.H., Delibes, M., Pontier, D., Kitchener, A.C., Yamaguchi, N., O'Brien, S.J., and Macdonald, D.W. (2007) The Near Eastern origin of cat domestication. Science 317, 519-523. (Pubitemid 47196117)
2. Paigen, K. One hundred years of mouse genetics: an intellectual history. I. The classical period (1902-1980). Genetics 163, 1-7.
3. Cuenot, L. (1902) La loi de Mendel et l'heredite de la pigmentation chez les souris. Arch. Zool. Exp. Gen. 3, 27-30.
4. Van Dyke, T. and Jacks, T. (2002) Cancer modeling in the modern era: progress and challenges. Cell 108, 5-15.
5. Paigen, K. One hundred years of mouse genetics: an intellectual history. II. The molecular revolution (1981-2002). Genetics 163, 1227-1235.
6. Gordon, J.W., Scangos, G.A., Plotkin, D.J., Barbosa, J.A., and Ruddle, F.H. (1980) Genetic transformation of mouse embryos by microinjection of purified DNA. Proc. Natl. Acad. Sci. USA 77, 7380-7384. (Pubitemid 11131133)
7. Brinster, R.L., Chen, H.Y., Trumbauer, M., Senear, A.W., Warren, R., and Palmiter, R.D. (1981) Somatic expression of herpes thymidine kinase in mice following injection of a fusion gene into eggs. Cell 27, 223-231. (Pubitemid 12205987)
8. Constantini, F. and Lacy, E. (1981) Introduction of a rabbit beta-globin gene into the mouse germ line. Nature 294, 92-94. (Pubitemid 12208163)
9. Harbers, K., Jahner, D., and Jaenisch, R. (1981) Microinjection of cloned viral genomes into mouse zygotes: integration and expression in the animal. Nature 293, 540-542. (Pubitemid 12208451)
10. Wagner, T.E., Hoppe, P.C., Jollick, J.D., Scholl, D.R., Hodinka, R.L., and Gault, J.B. (1981) Microinjection of a rabbit beta-globin gene into zygotes and its subsequent expression in adult mice and their offspring. Proc. Natl. Acad. Sci. USA 78, 6376-6380. (Pubitemid 12179715)
11. Jaenisch, R. (1988) Transgenic animals. Science 240, 1468-1474.
12. Greenberg, N.M., DeMayo, F.J., Finegold, M.J., Medina, D., Tilley, W.D., Aspinall, J.O., Cunha, G.R., Donjacour, A.A., Matusik, R.J., and Rosen, J.M. (1995) Prostate cancer in a transgenic mouse. Proc. Natl. Acad. Sci. USA 92, 3439-3443.
13. Gingrich, J.R., Barrios, R.J., Morton, R.A., Boyce, B.F., DeMayo, F.J., Finegold, M.J., Angelopoulou, R., Rosen, J.M., and Greenberg, N.M. (1996) Metastatic prostate cancer in a transgenic mouse. Cancer Res. 56, 4096-4102. (Pubitemid 26304996)
14. Kaplan-Lefko, P.J., Chen, T.M., Ittmann, M.M., Barrios, R.J., Ayala, G.E., Huss, W.J., Maddison, L.A., Foster, B.A., and Greenberg, N.M. (2003) Pathobiology of autochthonous prostate cancer in a preclinical transgenic mouse model. Prostate 55, 219-237. (Pubitemid 36532401)
15. Hurwitz, A.A., Foster, B.A., Kwong, E.D., Truong, T., Choi, E.M., Greenberg, N.M., Burg, M.B., and Allison, J.P. (2000) Com bination immunotherapy of primary prostate cancer in a transgenic mouse model using CTLA-4 blockade. Cancer Res. 60, 2444-2448. (Pubitemid 30262435)
16. Giraldo, P. and Montoliu, L. (2001) Size matters: use of YACs, BACs and PACs in transgenic animals. Transgenic Res. 10, 83-103. (Pubitemid 32235229)
17. Schedl, A., Larin, Z., Montoliu, L., Thies, E., Kelsey, G., Lehrach, H., and Schutz, G. (1993) A method for the generation of YAC transgenic mice by pronuclear microinjection. Nucl. Acids Res. 21, 4783-4787. (Pubitemid 23312755)
18. Smith, D.J., Stevens, M.E., Sudanagunta, S.P., Bronson, R.T., Makhinson, M., Watabe, A.M., O'Dell, T.J., Fung, J., Weier, H.U., Cheng, J.F., and Rubin, E.M. (1997) Functional screening of 2 Mb of human chromosome 21q22.2 in transgenic mice implicates minibrain in learning defects associated with Down syndrome. Nat. Genet. 16, 28-36. (Pubitemid 27198153)
19. Wagner, E.F., Stewart, T.A., and Mintz, B. (1981) The human ß-globin gene and a functional viral thymidine kinase gene in developing mice. Proc. Natl. Acad. Sci. USA 78, 5016-5020. (Pubitemid 12225613)
20. Wilson, C., Bellen, H.J., and Gehring, W.J. (1990) Position effects on eukaryotic gene expression. Annu. Rev. Cell. Biol. 6, 679-714.
21. Palmiter, R.D. and Brinster, R.L. (1986) Germ-line transformation of mice. Annu. Rev. Genet. 20, 465-499.
22. Furth, P.A., Hennighausen, L., Baker, C., Beatty, B., and Woychick, R. (1991) The variability in activity of the universally expressed human cytomegalovirus immediate early gene 1 enhancer/promoter in transgenic mice. Nucl. Acids Res. 19, 6205-6208. (Pubitemid 21913040)
23. Lewis, P.F. and Emerman, M. (1994) Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus. J. Virol. 68, 510-516.
24. Buchschacher, G.L. and Wong-Staal, F. (2000) Development of lentiviral vectors for gene therapy of human disease. Blood 95, 2499-2504. (Pubitemid 30210526)
25. Miller, A.D. (1990) Retrovirus packaging cells. Hum. Gene Ther. 1, 5-14. (Pubitemid 120034737)
26. Zuffrey, R., Donello, J.E., Trono, D., and Hope, T.J. (1999) Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors. J. Virol. 73, 2886-2892. (Pubitemid 29135675)
27. Lois, C., Hong, E.J., Pease, S., Brown, E.J., and Baltimore, D. (2002) Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors. Science 295, 868-872. (Pubitemid 34118370)
28. Imren, S., Farbry, M.E., Westerman, K.A., Pawliuk, R., Tang, P., Rosten, P.M., Nagel, R.L., Leboulch, P., Eaves, C.J., and Humphries, R.K. (2004) High level betaglobin expression and preferred intragenic integration after lentiviral transduction of human cord blood stem cells. J. Clin. Invest. 114, 953-962. (Pubitemid 39578723)
29. Schroder, A.R., Shinn, P., Chen, H., Berry, C., Ecker, J.R., and Bushman, F. (2002) HIV-1 integration in the human genome favors active genes and local hotspots. Cell 110, 521-529. (Pubitemid 35232295)
30. Dann, C.T. (2007) New technology for an old favorite: lentiviral transgenesis and RNAi in rats. Transgenic Res. 16, 571-580. (Pubitemid 47358581)
31. Jahner, D., Stuhlmann, H., Stewart, C.L., Harbers, K., Lohler, J., Simon, I., and Jaenisch, R. (1982) De novo methylation and expression of retroviral genomes during mouse embryogenesis. Nature 298, 623-628. (Pubitemid 12099716)
32. Van den Brandt, J., Wang, D., Kwon, S.H., Heinkelein, M., and Reichardt, H.M. (2004) Lentivirally generated eGFP-transgenic rats allow efficient cell tracking in vivo. Genesis 39, 94-99. (Pubitemid 38924656)
33. Capecchi, M.R. (1989) Altering the genome by homologous recombination. Science 244, 1288-1292. (Pubitemid 19170497)
34. Evans, M.J. and Kaufman, M.H. (1981) Establishment in culture of pluripotent cells from mouse embryos. Nature 292, 154-156. (Pubitemid 11050741)
35. Martin, G.R. (1981) Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc. Natl. Acad. Sci. USA 78, 7634-7636.
36. Abbondanzo, S.J., Gadi, I., and Stewart, C.L. (1993) Derivation of embryonic stem cell lines. Methods Enzymol. 225, 803-823.
37. Bradley, A., Evans, M., Kaufman, M.H., and Robertson, E. (1984) Formation of germ-line chimaeras from embryo derived teratocarcinoma cell lines. Nature 309, 255-256. (Pubitemid 14139934)
38. Doetschman, T., Gregg, R.G., Maeda, N., Hooper,M.L., Melton, D.W., Thompson, S., and Smithies, O. (1987) Targeted correction of a mutant HPRT gene in mouse embryonic stem cells. Nature 330, 576-578. (Pubitemid 17164356)
39. Koentgen, F. and Stewart, C.L. (1993) Simple screening procedure to detect gene targeting events in embryonic stem cells. Methods Enzymol. 225, 878-890. (Pubitemid 23301564)
40. Mansour, S., Thomas, K, and Capecchi, M.R. (1988) Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: a general strategy for targeting mutations to non-selectable genes. Nature 336, 348-352.
41. Branda, C.S. and Dymecki, S.M. (2004) Talking about a revolution: the impact of site-specific recombinases on genetic analyses in mice. Dev. Cell 6, 7-28. (Pubitemid 38089202)
42. Sauer, B. and Henderson, N. (1989) Crestimulated recombination at loxP-containing DNA sequences placed into the mammalian genome. Nucl. Acids Res. 17, 147-161. (Pubitemid 19030024)
43. O'Gorman, S., Fox, D.T., and Wahl, G.M. (1991) Recombinase-mediated gene activation and site-specific integration in mammalian cells. Science 251, 1351-1355. (Pubitemid 21916917)
44. Lewandoski, M. (2001) Conditional control of gene expression in the mouse. Nat. Rev. Genet. 2, 743-755. (Pubitemid 33685572)
45. Forlino, A., Porter, F.D., Lee, E.J., Westphal, H., and Marini, J.C. (1999) Use of Cre/lox recombination system to develop a non-lethal knock-in murine model for osteogenesis imperfecta with an alpha1(I) G349C substitution. J. Biol. Chem. 274, 37923-37931. (Pubitemid 30026860)
46. Gu, H., Marth, J.D., Orban, P.C., Mossmann, H., and Rajewsky, K. (1994) Deletion of a DNA polymerase beta gene segment in T cells using cell type-specific gene targeting. Science 265, 103-106.
47. Furuta, Y. and Behringer, R.R. (2005) Recent innovations in tissue-specific gene modifications in the mouse. Birth Defects Res 75, 43-57. (Pubitemid 40604934)
48. Nagy, A. (2000) Cre recombinase: the universal reagent for genome tailoring. Genesis 26, 99-109. (Pubitemid 30158089)
49. Feil, R., Brocard, J., Mascrez, B., LeMeur, M., Metzger, D., and Chambon, P. (1996) Ligand-activated site-specific recombination in mice. Proc. Natl. Acad. Sci. USA 93, 10887-10890. (Pubitemid 26333086)
50. Danielian, P.S.,Muccino, D., Rowitch, D.H., Michael, S.K., and MacMahon, A.P. (1998) Modification of gene activity in mouse embryos in utero by a tamoxifen-inducible form of Cre recombinase. Curr. Biol. 8, 1323-1326. (Pubitemid 29006707)
51. Schwenk F., Kuehn R., Angrand, P.-O., Rajewsky K., and Stewart, A.F. (1998) Temporally and spatially regulated somatic mutagenesis in mice. Nucl. Acids Res. 26, 1427-1432. (Pubitemid 28291617)
52. Kellendonk, C., Tronche, F., Monaghan, A.P., Angrand, P.O., Stewart, F., and Schuetz, G. (1996) Regulation of Cre recombinase activity by the synthetic steroid RU486. Nucl. Acids Res. 24, 1404-1411. (Pubitemid 26118971)
53. Feil, R., Wagner, J., Metzger, D., and Chambon, P. (1997) Regulation of Cre recombinase activity by mutated estrogen receptor ligand-binding domains. Biochem. Biophys. Res. Commun. 237, 752-757. (Pubitemid 27434760)
54. Skvorak, K., Vissel, B., and Homanis, G.E. (2006) Production of conditional point mutant knockin mice. Genesis 44, 345-353. (Pubitemid 44182451)
55. Albert, H., Dale, E.C., Lee, E., and Ow, D.W. (1995) Site-specific integration of DNA into wild-type and mutant lox sites placed in the plant genome. Plant J. 7, 649-659.
56. Zhang, Z. and Lutz, B. (2002) Cre recombinase-mediated inversion using lox66 and lox71: method to introduce conditional point mutations into the CREB-binding protein. Nucl. Acids Res. 30, e90.
57. Schnuetgen, F., Doerflinger, N., Calleja, C., Wendling, O., Chambon, P., and Ghyselinck, N.B. (2003) A directional strategy for monitoring Cre-mediated recombination at the cellular level in the mouse. Nat. Biotechnol. 21, 562-565. (Pubitemid 36532023)
58. Schnuetgen, F., De-Zolt, S., Van Sloun, P., Hollatz, M., Floss, T., Hansen, J., Altschmied, J., Seisenberger, C., Ghyselinck, N.B., Ruiz, P., Chambon, P., Wurst, W., and von Melchner, H. (2005) Genomewide production of multipurpose alleles for the functional analysis of the mouse genome. Proc. Natl. Acad. Sci. USA 102, 7221-7226. (Pubitemid 40696360)
59. Bayascas, J.R., Sakamoto, K., Armit, L., Arthur, J.S.C., and Alessi, D.R. (2006) Evaluation of approaches to generation of tissuespecific knock-in mice. J. Biol. Chem. 281, 28772-28781. (Pubitemid 44507020)
60. Pelletier, J. and Sonnenberg, N. (1988) Internal initiation of translation of eukaryotic mRNA directed by a sequence derived from poliovirus RNA. Nature 334, 320-325.
61. Jang, S.K., Krausslich, H.G., Nicklin, M.J., Duke, G.M., Palmenberg, A.C., and Wimmer, E. (1988) A segment of the 5nontranslated region of encephalomyocarditis virus RNA directs internal entry of ribosomes during in vitro translation. J. Virol. 62, 2636-2643.
62. Bochov, Y.A. and Palmenberg, A.C. (2006) Translational efficiency of EMCV IRES in bicistronic vectors is dependent upon IRES sequence and gene location. BioTechniques 41, 283-292. (Pubitemid 46534891)
63. Mizuguchi, H., Xu, Z., Ishii-Watabe, A., Uchida, E., and Hayakawa, T. (2000) IRESdependent second gene expression is significantly lower than cap-dependent first gene expression in a bicistronic vector. Mol. Ther. 1, 376-382.
64. Okabe, M., Ikawa, M., Kominami, K., Nakanishi, T., and Nishimune, Y. (1997) Green mice as a source of ubiquitous green cells. FEBS Lett. 407, 313-319. (Pubitemid 27199450)
65. Hadjantonakis, A.K., Gertsenstein, M., Ikawa, M., Okabe, M., and Nagy, A. (1998) Generating green fluorescent mice by germline transmission of green fluorescent ES cells. Mech. Dev. 76, 79-90. (Pubitemid 28467905)
66. Shaner, N.C., Steinbach, P.A., and Tsien, R.Y. (2005) A guide to choosing fluorescent proteins. Nat. Methods 2, 905-909. (Pubitemid 43108726)
67. Hadjantonakis, A.K., Dickinson, M.E., Fraser, S.E., and Papaiannou, V.E. (2003) Technicolour transgenics: imaging tools for functional genomics in the mouse. Nat. Rev. Genet. 4, 613-625. (Pubitemid 36917503)
68. Livet, J., Weissmann, T.A., Kang, H., Draft, R.W., Lu, J., Bennis, R.A., Sanes, J.R., and Lichtman, J.W. (2007) Transgenic strategies for combinatorial expression of fluorescent proteins in the nervous system. Nature 450, 56-62. (Pubitemid 350070576)
69. Hopkin, M. (2006) Can super-antibody drugs be tamed? Nature 440, 855-856.
70. Lee, H., Zahra, D., Vogelzang, A., Newton, R., Thatcher, R., Quan, A., So, T., Zwirner, J., Koentgen, F., Padkjaer, S., Mackay, F., Whitfield, P.L., and Mackay, C.R. (2006) Human C5aR knock-in mice facilitate the production and assessment of antiinflammatory monoclonal antibodies. Nat. Biotechnol. 24, 1279-1284. (Pubitemid 44564775)
71. Le, Y., Gagneten, S., Larson, T., Santha, E., Dobi, A., Agoston, D., and Sauer, B. (2003) Far-upstream elements are dispensable for tissue-specific proenkephalin expression using a Cre-mediated knock-in strategy. J. Neurochem. 84, 689-697. (Pubitemid 36176927)
72. Nyhan, W.L. (1997) The recognition of Lesch-Nyhan syndrome as an inborn error of purine metabolism. J. Inherit. Metab. Dis. 20, 171-178. (Pubitemid 27273480)
73. Williamson, D.J., Hooper, M.L., and Melton, D.W. (1992) Mouse models of hypoxanthine phosphoribosyltransferase deficiency. J. Inherit. Metab. Dis. 15, 665-673.
74. Oberdoerffer. P., Kanellopoulou, C., Heissmeyer, V., Paeper, C., Borowski, C., Aifantis, I., Rao, A., and Rajewsky, K. (2005) Efficiency of RNA interference in the mouse hematopoietic system varies between cell types and developmental stages. Mol. Cell. Biol. 25, 3896-3905. (Pubitemid 40617641)
75. Bronson, S.K., Plaehn, E.G., Kluckman, K.D., Hagaman, J.R., Maeda, N., and Smithies, O. (1996) Single-copy transgenic mice with chosen-site integration. Proc. Natl. Acad. Sci. USA 93, 9067-9072. (Pubitemid 26282019)
76. Hatada, S., Kuziel, W., Smithies, O., and Maeda, N. (1999) The influence of chromosomal location on the expression of two transgenes in mice. J. Biol. Chem. 274, 948-955.
77. Friedrich, G. and Soriano, P. (1991) Promoter traps in embryonic stem cells: a genetic screen to identify and mutate developmental genes in mice. Genes Dev. 5, 1513-1523. (Pubitemid 21906058)
78. Zambrowicz, B.P., Imamoto, A., Fiering, S., Herzenberg, L.A., Kerr, W.G., and Soriano, P. (1997) Disruption of overlapping transcripts in the ROSA geo 26 gene trap strain leads to widespread expression of beta-galactosidase in mouse embryos and hematopoietic cells. Proc. Natl. Acad. Sci. USA 94, 3789-3794. (Pubitemid 27180451)
79. Irion, S., Luche, H., Gadue, P., Fehling, H.J., Kennedy, M., and Keller, G. (2007) Identification and targeting of the ROSA26 locus in human embryonic stem cells. Nat. Biotech. 25, 1477-1482. (Pubitemid 350233137)
80. Kisseberth, W.C., Brettingen, N.T., Lohse, J.K., and Sandgren, E.P. (1999) Ubiquitous expression of marker transgenes in mice and rats. Dev. Biol. 128-138. (Pubitemid 29463361)
81. Strathdee, D., Ibbotson, H., and Grant, S.G.N. (2006) Expression of transgenes targeted to the Gt(ROSA)26Sor locus is orientation dependent. PloS ONE 1, e4.
82. Lai, K.M.V., Gonzalez, M., Poueymirou, W.T., Kline, W.O., Na, E., Zlotchenko, E., Stitt, T.N., Economides, A.N., Yancopoulos, G.D., and Glass, D.J. (2004) Conditional activation of Akt in adult skeletal muscle induces rapid hypertrophy. Mol. Cell. Biol. 24, 9295-9304. (Pubitemid 39391668)
83. Lakso, M., Sauer, B., Mosinger, B., Lee, E.J., Manning, R.W., Yu, S.H., Mulder, K.L., and Westphal, H. (1992). Targeted oncogene activation by site-specific recombination in transgenic mice. Proc. Natl. Acad. Sci. USA 89, 6232-6236.
84. Jackson, E.L., Willis, N., Mercer, K., Bronson, R.T., Crowley, D., Montoya, R., Jacks, T., and Tuveson, D.A. (2001) Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. Genes Dev. 15, 3243-3248. (Pubitemid 34008190)
85. Fire, A., Xu, S., Montgomery, M.K., Kostas, S.S., Driver, S.E., and Mello, C.C. (1998) Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391, 806-811. (Pubitemid 28099681)
86. McManus, M.T. and Sharp, P.A. (2002) Gene silencing in mammals by small interfering RNAs. Nat. Rev. Genet. 3, 737-747.
87. Hannon, G.J. (2002) RNA interference. Nature 418, 244-251. (Pubitemid 34773784)
88. Novina, C.D. and Sharp, P.A. (2004) The RNAi revolution. Nature 430, 161-164. (Pubitemid 38902417)
89. Ui-Tei, K., Naito, Y., Takahashi, F., Haraguchi, T., Ohki-Hamazaki, H., Juni, A., Ueda, R., and Saigo, K. (2004) Guidelines for the selection of highly effective siRNA sequences for mammalian and chick RNA interference. Nucl. Acids Res. 32, 936-948. (Pubitemid 38854696)
90. Meister, G. and Tuschl, T. (2004) Mechanisms of gene silencing by double-stranded RNA. Nature 431, 343-349. (Pubitemid 39265674)
91. Hasuwa, H., Kaseda, K., Einarsdottir, T., and Okabe, M. (2002) Small interfering RNA and gene silencing in transgenic mice and rats. FEBS Lett. 532, 227-230. (Pubitemid 35375894)
92. Mitani, T. and Yokota, T. (2005) RNA interference as a tool for producing knockdown mice. J. Mamm. Ova Res. 22, 139-151.
93. Hou, J., Schan, Q., Wang, T., Gomes, A.S., Yan, Q.S., Paul, D.L., Bleich, M., and Goodenough, D.A. (2007) Transgenic RNAi depletion of claudin-16 and the renal handling of magnesium. J. Biol. Chem. 282, 17114-17122. (Pubitemid 47093227)
94. Lu, W., Yamamoto, V., Ortega, B., and Baltimore, D. (2004) Mammalian Ryk is a Wnt coreceptor required for stimulation of neurite outgrowth. Cell 119, 97-108. (Pubitemid 39349323)
95. Kissler, S., Stern, P., Takahashi, K., Hunter, K., Peterson, L.B., and Wicker, L.S. (2006) In vivo RNA interference demonstrates a role for Nramp1 in modifying susceptibility to type 1 diabetes. Nat. Genet. 38, 479-483.
96. Grimm D., Streetz, K.L., Jopling, C.L., Storm, T.A., Pandey, K., Davis, C.R., Marion, P., Salzar, F., and Kay, M.A. (2006). Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways. Nature 441, 537-541. (Pubitemid 44050158)
97. Amar, L., Desclaux, M., Faucon-Biguet, N., Mallet, J., and Vogel, R. (2006) Control of small inhibitory RNA levels and RNA interference by doxycycline induced activation of a minimal RNA polymerase III promoter. Nucl. Acids Res. 34, e37.
98. Szulc, J., Wiznerowicz, M., Sauvain, M.-O., Trono, D., and Aebischer, P. (2006). A versatile tool for conditional gene expression and knockdown. Nat. Methods 3, 109-116. (Pubitemid 43173309)
99. Moosmann, P. Georgiev, O., Thiesen, H.J., Hagmann, M., and Schaffner, W. (1997) Silencing of RNA polymerases II and IIIdependent transcription by the KRAB protein domain of KOX1, a Kruppel-type zinc finger factor. Biol. Chem. 378, 669-677. (Pubitemid 27361859)
100. Fritsch, L., Martinez, L.A., Sekhri, R., Naguibneva, I., Gerard, M., Vandromme, M., Schaeffer, L., and Harel-Bellan, A. (2004) Conditional gene knock-down by Cre-dependent short interfering RNAs. EMBO Rep. 5, 178-182. (Pubitemid 38401198)
101. Hitz, C., Wurst, W., and Kuhn, R. (2007) Conditional brain-specific knockdown of MAPK using Cre/loxP regulated RNA interference. Nucl. Acids Res. 35, e90.
102. Steuber-Buchberger, P., Wurst, W., and Kuhn, R. (2008) Simultaneous cre-mediated conditional knockdown of two genes in mice. Genesis 46, 144-151. (Pubitemid 351554743)
103. Tiscornia, G., Tergaonkar, V., Galimi, F., and Verma, I.M. (2004) Cre recombinaseinducible RNA interference mediated by lentiviral vectors. Proc. Natl. Acad. Sci. USA 101, 7347-7351. (Pubitemid 38638035)